Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ischemic Heart Disease

  Free Subscription

26.02.2024

4 Am Heart J
4 Am J Cardiol
1 Am J Med
1 Angiology
1 Ann Intern Med
1 Atherosclerosis
2 BMJ
3 Can J Cardiol
2 Cardiovasc Res
1 Catheter Cardiovasc Interv
9 Circ Cardiovasc Imaging
1 Circ Cardiovasc Qual Outcomes
1 Circ Genom Precis Med
1 Circ Heart Fail
2 Circ J
3 Circulation
3 Clin Cardiol
1 Crit Care Med
4 Eur Heart J
2 Heart
4 Hypertension
12 Int J Cardiol
3 J Am Coll Cardiol
1 J Clin Endocrinol Metab
1 J Clin Epidemiol
1 J Nucl Med
1 Lancet
1 Mol Cell Biochem
6 N Engl J Med
1 PLoS One



    Am Heart J

  1. ODDLEIFSON DA, Zheng Z, Wadhera RK
    Out-of-Pocket Prescription Drug Costs for Adults with Cardiovascular Risk Factors Under Amazon's Direct-to-Consumer Pharmacy Service.
    Am Heart J. 2024 Feb 14:S0002-8703(24)00031-0. doi: 10.1016/j.ahj.2024.
    >> Share

  2. KANTHASAMY V, Schilling R, Zongo O, Khan K, et al
    Feasibility of Double-Blinded, Placebo-Controlled Interventional Study for Assessing Catheter Ablation Efficacy in Persistent Atrial Fibrillation: Insights from the ORBITA AF Feasibility study.
    Am Heart J. 2023 Dec 16:S0002-8703(23)00353-8. doi: 10.1016/j.ahj.2023.
    >> Share

  3. ANAND SS, Aboyans V, Bosch J, Debus S, et al
    Identifying the highest risk vascular patients: Insights from the XATOA registry.
    Am Heart J. 2024;269:191-200.
    >> Share

  4. ABU-MUCH A, Grines CL, Batchelor WB, Maini AS, et al
    Influence of Left Ventricular Ejection Fraction in Patients Undergoing Contemporary pLVAD-Supported High-Risk PCI.
    Am Heart J. 2023 Dec 25:S0002-8703(23)00358-7. doi: 10.1016/j.ahj.2023.
    >> Share


    Am J Cardiol

  5. TARANTINI G, Cardaioli F
    Navigating The Challenges of Redo-Transcatheter Aortic Valve Replacement: Predicting Sinus Sequestration and Coronary Obstruction in The Era Of Expanding Treatment.
    Am J Cardiol. 2023 Nov 10:S0002-9149(23)01312.
    >> Share

  6. GUTIERREZ-BARRIOS A, Canadas-Pruano D, Alfaro LM, Gheorghe L, et al
    Coronary Flow Reserve and Myocardial Resistance Reserve Changes After Transcatheter Aortic Valve Implantation in Aortic Stenosis.
    Am J Cardiol. 2024 Jan 15:S0002-9149(24)00031.
    >> Share

  7. PERERA S, Zheng Z, Wadhera R
    Cardiovascular Health, Lifestyle Factors, and Social Determinants Among Asian Sub-Populations in the US.
    Am J Cardiol. 2024 Feb 16:S0002-9149(24)00098.
    >> Share

  8. AGARWAL S, Qamar U, Fujiwara Y, Guha A, et al
    The Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Cardiovascular Outcomes in Patients with Cancer: A Systematic Review and Meta-Analysis.
    Am J Cardiol. 2024 Feb 17:S0002-9149(24)00101.
    >> Share


    Am J Med

  9. KRITTANAWONG C, Uppalapati L, Virk HUH, Qadeer YK, et al
    Complications of Radial vs Femoral Access For Coronary Angiography and Intervention: What Do The Data Tell Us?
    Am J Med. 2024 Feb 20:S0002-9343(24)00107-4. doi: 10.1016/j.amjmed.2024.
    >> Share


    Angiology

  10. SAYLIK F, Kumet O, Sarikaya R, Akbulut T, et al
    Bendopnea Predicts High SYNTAX Score in Patients With Coronary Artery Disease: A Bayesian Approach.
    Angiology. 2024 Feb 22:33197241235957. doi: 10.1177/00033197241235957.
    >> Share


    Ann Intern Med

  11. WEITZ HH, Merli GJ
    Web Exclusive. Annals Consult Guys - Reversals of Care Started After a Myocardial Infarction.
    Ann Intern Med. 2024;177:eW230013.
    >> Share


    Atherosclerosis

  12. LARSSON J, Auscher S, Shamoun A, Pararajasingam G, et al
    Insulin resistance is associated with high-risk coronary artery plaque composition in asymptomatic men between 65 and 75 years and no diabetes: A DANCAVAS cross-sectional sub-study.
    Atherosclerosis. 2023;385:117328.
    >> Share


    BMJ

  13. SUN Y, Milando CW, Spangler KR, Wei Y, et al
    Short term exposure to low level ambient fine particulate matter and natural cause, cardiovascular, and respiratory morbidity among US adults with health insurance: case time series study.
    BMJ. 2024;384:e076322.
    >> Share

  14. WEI Y, Feng Y, Danesh Yazdi M, Yin K, et al
    Exposure-response associations between chronic exposure to fine particulate matter and risks of hospital admission for major cardiovascular diseases: population based cohort study.
    BMJ. 2024;384:e076939.
    >> Share


    Can J Cardiol

  15. DEL PORTILLO JH, Farjat-Pasos J, Galhardo A, Avvedimento M, et al
    Aortic Stenosis With Coronary Artery Disease: SAVR or TAVR-When and How?
    Can J Cardiol. 2024;40:218-234.
    >> Share

  16. BAINEY KR, Marquis-Gravel G, Belley-Cote E, Turgeon RD, et al
    Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology 2023 Focused Update of the Guidelines for the Use of Antiplatelet Therapy.
    Can J Cardiol. 2024;40:160-181.
    >> Share

  17. VERVOORT D, Sud M, Zeis TM, Haouzi AA, et al
    Do the Few Dictate Care for the Many? Revascularisation Considerations That Go Beyond the Guidelines.
    Can J Cardiol. 2024;40:275-289.
    >> Share


    Cardiovasc Res

  18. PACKARD CJ, Pirillo A, Tsimikas S, Ference BA, et al
    Exploring apolipoprotein C-III: pathophysiological and pharmacological relevance.
    Cardiovasc Res. 2024;119:2843-2857.
    >> Share

  19. TERENZI DC, Bakbak E, Teoh H, Krishnaraj A, et al
    Restoration of blood vessel regeneration in the era of combination SGLT2i and GLP-1RA therapy for diabetes and obesity.
    Cardiovasc Res. 2024;119:2858-2874.
    >> Share


    Catheter Cardiovasc Interv

  20. CORCIONE N, Biondi-Zoccai G
    ABC as in Arteriopathy, Bleeding, and Coronary disease: Disentangling the prognostic conundrum of patients undergoing percutaneous coronary intervention with concomitant peripheral artery disease.
    Catheter Cardiovasc Interv. 2024 Feb 22. doi: 10.1002/ccd.30982.
    >> Share


    Circ Cardiovasc Imaging

  21. MARZLIN N, Chapel A, Adefisoye J, Garg K, et al
    Differences and Disparities Among Self-Referred and Physician-Referred Populations Undergoing Coronary Artery Calcium Scanning.
    Circ Cardiovasc Imaging. 2024;17:e015712.
    >> Share

  22. RUBERG FL, Gropler RJ
    In This Issue of the Journal.
    Circ Cardiovasc Imaging. 2024;17:e016675.
    >> Share

  23. DAI N, Tang X, Weng X, Cai H, et al
    Sex Differences in Coronary Inflammation and Atherosclerosis Phenotypes in Response to Imaging Marker of Stress-Related Neural Activity.
    Circ Cardiovasc Imaging. 2024;17:e016057.
    >> Share

  24. KINOSHITA D, Suzuki K, Yuki H, Niida T, et al
    Sex-Specific Association Between Perivascular Inflammation and Plaque Vulnerability.
    Circ Cardiovasc Imaging. 2024;17:e016178.
    >> Share

  25. AUN JA, Blankstein R
    Equity in Cardiovascular Disease Prevention: A Case for Universal Coverage of Calcium Scoring.
    Circ Cardiovasc Imaging. 2024;17:e016516.
    >> Share

  26. MIKAIL N, Gebhard C
    L'Equilibre Perilleux: Mental Stress and Inflammation in Women.
    Circ Cardiovasc Imaging. 2024;17:e016525.
    >> Share

  27. PATEL KK, Shaw LJ
    Perivascular Adipose Tissue Inflammation: Does It Explain Sex-Based Differences in Atherosclerotic Heart Disease?
    Circ Cardiovasc Imaging. 2024;17:e016559.
    >> Share

  28. ZHAN Y, Friedrich MG, Dendukuri N, Lu Y, et al
    Meta-Analysis of Normal Reference Values for Right and Left Ventricular Quantification by Cardiovascular Magnetic Resonance.
    Circ Cardiovasc Imaging. 2024;17:e016090.
    >> Share

  29. DONG T, Wang TKM
    Nuances in Defining Normal Ranges for Chamber Quantification With Cardiovascular Magnetic Resonance.
    Circ Cardiovasc Imaging. 2024;17:e016488.
    >> Share


    Circ Cardiovasc Qual Outcomes

  30. KHAZANIE P, Kramer DB
    Centering Medical Ethics Into Cardiovascular Medicine.
    Circ Cardiovasc Qual Outcomes. 2024;17:e010870.
    >> Share


    Circ Genom Precis Med

  31. SMITH JL, Tcheandjieu C, Dikilitas O, Iyer K, et al
    Multi-Ancestry Polygenic Risk Score for Coronary Heart Disease Based on an Ancestrally Diverse Genome-Wide Association Study and Population-Specific Optimization.
    Circ Genom Precis Med. 2024 Feb 21:e004272. doi: 10.1161/CIRCGEN.123.004272.
    >> Share


    Circ Heart Fail

  32. MOAYEDI Y, Rodenas-Alesina E, Somerset E, Fan CPS, et al
    Enhancing the Prediction of Cardiac Allograft Vasculopathy Using Intravascular Ultrasound and Machine Learning: A Proof of Concept.
    Circ Heart Fail. 2024 Feb 5:e011306. doi: 10.1161/CIRCHEARTFAILURE.123.011306.
    >> Share


    Circ J

  33. YOSHIFUJI H, Nakaoka Y, Uchida HA, Sugihara T, et al
    Organ Damage and Quality of Life in Takayasu Arteritis?- Evidence From a National Registry Analysis.
    Circ J. 2024;88:285-294.
    >> Share

  34. SUZUKI Y, Kaneko H, Okada A, Fujiu K, et al
    Benign Prostatic Hyperplasia and Incident Cardiovascular Disease.
    Circ J. 2024;88:408-416.
    >> Share


    Circulation

  35. PRAPIADOU S, Zivkovic L, Thorand B, George MJ, et al
    Proteogenomic Data Integration Reveals CXCL10 as a Potentially Downstream Causal Mediator for IL-6 Signaling on Atherosclerosis.
    Circulation. 2023 Dec 28. doi: 10.1161/CIRCULATIONAHA.123.064974.
    >> Share

  36. MOCUMBI AO
    Cardiovascular Health Care in Low- and Middle-Income Countries.
    Circulation. 2024;149:557-559.
    >> Share

  37. STOREY RF
    Antiplatelet Therapy After PCI: The Art and Science of De-Escalation.
    Circulation. 2024;149:601-604.
    >> Share


    Clin Cardiol

  38. KAWADA T
    Comment on "Association of kidney disease index with all-cause and cardiovascular mortality among individuals with hypertension".
    Clin Cardiol. 2024;47:e24242.
    >> Share

  39. ERGUI I, Salama J, Hooda U, Ebner B, et al
    In-hospital outcomes in unhoused patients with cardiogenic shock in the United States: Insights from The National Inpatient Sample 2011-2019.
    Clin Cardiol. 2024;47:e24235.
    >> Share

  40. KLONER RA, Stanek E, Desai K, Crowe CL, et al
    The association of tadalafil exposure with lower rates of major adverse cardiovascular events and mortality in a general population of men with erectile dysfunction.
    Clin Cardiol. 2024;47:e24234.
    >> Share


    Crit Care Med

  41. THEVATHASAN T, Fureder L, Fechtner M, Mork SR, et al
    Left-Ventricular Unloading With Impella During Refractory Cardiac Arrest Treated With Extracorporeal Cardiopulmonary Resuscitation: A Systematic Review and Meta-Analysis.
    Crit Care Med. 2024;52:464-474.
    >> Share


    Eur Heart J

  42. TARANTINI G, Putorti F, Nai Fovino L
    10-Year optical coherence tomography follow-up of 'full-plastic jacket' with bioresorbable vascular scaffolds.
    Eur Heart J. 2024;45:556.
    >> Share

  43. NISHIHIRA K, Asano Y, Shibata Y
    Efficacy of paclitaxel-coated balloon angioplasty combined with intensive lipid-lowering therapy for ST-segment elevation myocardial infarction: insights from near-infrared spectroscopy.
    Eur Heart J. 2024 Feb 15:ehae073. doi: 10.1093.
    >> Share

  44. BARILE L, Marban E
    Injury minimization after myocardial infarction: focus on extracellular vesicles.
    Eur Heart J. 2024 Feb 15:ehae089. doi: 10.1093.
    >> Share

  45. KUMAR A, Vora K, Bhatt DL, Dharmakumar R, et al
    The Canadian Cardiovascular Society Classification of acute atherothrombotic myocardial infarction provides a novel staging scheme based on tissue injury severity.
    Eur Heart J. 2024 Feb 17:ehad821. doi: 10.1093.
    >> Share


    Heart

  46. DIRJAYANTO VJ, Alkhalil M, Dodson J, Mills G, et al
    Cognitive impairment and outcomes in older adults with non-ST-elevation acute coronary syndrome.
    Heart. 2023 Oct 9:heartjnl-2023-323224. doi: 10.1136/heartjnl-2023-323224.
    >> Share

  47. DEMANDT J, Koks A, Sagel D, van Hattem VAE, et al
    Prehospital risk assessment and direct transfer to a percutaneous coronary intervention centre in suspected acute coronary syndrome.
    Heart. 2023 Dec 1:heartjnl-2023-323346. doi: 10.1136/heartjnl-2023-323346.
    >> Share


    Hypertension

  48. CHOI E, Shimbo D, Chen L, Foti K, et al
    Trends in All-Cause, Cardiovascular, and Noncardiovascular Mortality Among US Adults With Hypertension.
    Hypertension. 2024 Feb 23. doi: 10.1161/HYPERTENSIONAHA.123.22220.
    >> Share

  49. NORTON GR, An DW, Aparicio LS, Yu YL, et al
    Mortality and Cardiovascular End Points In Relation to the Aortic Pulse Wave Components: An Individual-Participant Meta-Analysis.
    Hypertension. 2024 Feb 23. doi: 10.1161/HYPERTENSIONAHA.123.22036.
    >> Share

  50. MANTA E, Thomopoulos C, Kariori M, Polyzos D, et al
    Revisiting Cardiovascular Benefits of Blood Pressure Reduction in Primary and Secondary Prevention: Focus on Targets and Residual Risk-A Systematic Review and Meta-Analysis.
    Hypertension. 2024 Feb 23. doi: 10.1161/HYPERTENSIONAHA.123.22610.
    >> Share

  51. MATTSSON K, Pihlsgard M, Enhorning S, Timpka S, et al
    Incident Cardiovascular Disease in Women With Type 1 or Type 2 Diabetes Following a Hypertensive Disorder of Pregnancy.
    Hypertension. 2024 Feb 22. doi: 10.1161/HYPERTENSIONAHA.123.22081.
    >> Share


    Int J Cardiol

  52. KAVSAK PA, Worster A
    The clinical chemistry score (CCS) achieves the highest efficacy when assessed with the 99% sensitivity benchmark for myocardial infarction.
    Int J Cardiol. 2024 Feb 20:131898. doi: 10.1016/j.ijcard.2024.131898.
    >> Share

  53. IANNACCONE M, Franchin L
    Reply to: Supported PCI reduced one-year all-cause mortality compared to standard PCI?
    Int J Cardiol. 2024;400:131707.
    >> Share

  54. XIA B, Ding J, Li Q, Zheng K, et al
    Reply to "Loganin: A potential pharmacological agent for myocardial ischemia-reperfusion injury".
    Int J Cardiol. 2024;400:131760.
    >> Share

  55. YANG C, Sui YG, Shen JY, Guan CD, et al
    Diagnostic performance of ultrasonic flow ratio versus quantitative flow ratio for assessment of coronary stenosis.
    Int J Cardiol. 2024;400:131765.
    >> Share

  56. ABDELAZIZ A, Elsayed H, Atta K, Mechi A, et al
    A comprehensive guide on the optimal timing of PCI in the setting of acute coronary syndrome: An updated meta-analysis.
    Int J Cardiol. 2024;400:131774.
    >> Share

  57. DREGOESC MI, Tigu AB, Bekkering S, van der Heijden CDCC, et al
    Intermediate monocytes are associated with the first major adverse cardiovascular event in patients with stable coronary artery disease.
    Int J Cardiol. 2024 Jan 11:131780. doi: 10.1016/j.ijcard.2024.131780.
    >> Share

  58. LIU Y, Cheng X, Qi B, Wang Y, et al
    Aucubin protects against myocardial ischemia-reperfusion injury by regulating STAT3/NF-kappaB/HMGB-1 pathway.
    Int J Cardiol. 2024;400:131800.
    >> Share

  59. ORTEGA-PAZ L, Bonaca M, Angiolillo DJ
    Optimizing LDL-cholesterol management in ACS patients: Breaking inertia and implementing intensified therapies.
    Int J Cardiol. 2024;400:131803.
    >> Share

  60. KOTOKU N, Ninomiya K, Masuda S, Tsai TY, et al
    Geographic disparity of pathophysiological coronary artery disease characteristics: Insights from ASET trials.
    Int J Cardiol. 2024;400:131805.
    >> Share

  61. GONZALEZ-URBISTONDO F, Alperi A
    muQFR in ASET Pilot Studies: More Assets in the decision-making process for stable ischemic heart disease.
    Int J Cardiol. 2024 Feb 17:131880. doi: 10.1016/j.ijcard.2024.131880.
    >> Share

  62. KASSEM M, Ayala PL, Andric-Cancarevic T, Tajsic M, et al
    Copeptin for the differentiation of type 1 versus type 2 myocardial infarction or myocardial injury.
    Int J Cardiol. 2024 Feb 16:131879. doi: 10.1016/j.ijcard.2024.131879.
    >> Share

  63. ZHAO J, Wu T, Tan J, Chen Y, et al
    Pancoronary plaque characteristics in STEMI patients with rapid plaque progression: An optical coherence tomography study.
    Int J Cardiol. 2024;400:131821.
    >> Share


    J Am Coll Cardiol

  64. JI H, Gulati M, Huang TY, Kwan AC, et al
    Sex Differences in Association of Physical Activity With All-Cause and Cardiovascular Mortality.
    J Am Coll Cardiol. 2024;83:783-793.
    >> Share

  65. MARTINEZ MW, Ackerman MJ, Annas GJ, Baggish AL, et al
    Sports Participation by Athletes With Cardiovascular Disease.
    J Am Coll Cardiol. 2024;83:865-868.
    >> Share

  66. BOTTINOR W, Im C, Doody DR, Armenian SH, et al
    Mortality After Major Cardiovascular Events in Survivors of Childhood Cancer.
    J Am Coll Cardiol. 2024;83:827-838.
    >> Share


    J Clin Endocrinol Metab

  67. KIM MK, Lee KN, Han K, Lee SH, et al
    Diabetes duration, cholesterol levels, and risk of cardiovascular diseases in individuals with type 2 diabetes.
    J Clin Endocrinol Metab. 2024 Feb 15:dgae092. doi: 10.1210.
    >> Share


    J Clin Epidemiol

  68. MESIDOR M, Sirois C, Guertin JR, Schnitzer ME, et al
    Effect of statin use for the primary prevention of cardiovascular disease among older adults: A cautionary tale concerning target trials emulation.
    J Clin Epidemiol. 2024 Feb 15:111284. doi: 10.1016/j.jclinepi.2024.111284.
    >> Share


    J Nucl Med

  69. SLART RHJA, Bengel FM, Akincioglu C, Bourque JM, et al
    Total-Body PET/CT Applications in Cardiovascular Diseases: A Perspective Document of the SNMMI Cardiovascular Council.
    J Nucl Med. 2024 Feb 22:jnumed.123.266858. doi: 10.2967/jnumed.123.266858.
    >> Share


    Lancet

  70. PATTERSON T, Perkins GD, Perkins A, Clayton T, et al
    Expedited transfer to a cardiac arrest centre for non-ST-elevation out-of-hospital cardiac arrest (ARREST): a UK prospective, multicentre, parallel, randomised clinical trial.
    Lancet. 2023;402:1329-1337.
    >> Share


    Mol Cell Biochem

  71. ZENG Q, Jiang T
    Molecular mechanisms of ferroptosis in cardiovascular disease.
    Mol Cell Biochem. 2024 Feb 19. doi: 10.1007/s11010-024-04940.
    >> Share


    N Engl J Med

  72. TAQUETI VR, Shaw LJ
    Semaglutide and Cardiovascular Outcomes.
    N Engl J Med. 2024;390:766.
    >> Share

  73. BELALCAZAR LM, Kuo YF
    Semaglutide and Cardiovascular Outcomes.
    N Engl J Med. 2024;390:766-767.
    >> Share

  74. BELKHOURIBCHIA J
    Semaglutide and Cardiovascular Outcomes.
    N Engl J Med. 2024;390:767.
    >> Share

  75. CAMPBELL LA, Jenkins AV, Jackson CD
    Semaglutide and Cardiovascular Outcomes.
    N Engl J Med. 2024;390:767.
    >> Share

  76. NEVES JS, Leite AR, Ferreira JP
    Semaglutide and Cardiovascular Outcomes.
    N Engl J Med. 2024;390:767-768.
    >> Share

  77. LINCOFF AM, Ryan DH, Esbjerg S
    Semaglutide and Cardiovascular Outcomes. Reply.
    N Engl J Med. 2024;390:768-769.
    >> Share


    PLoS One

  78. STANTON AM, Boyd RL, O'Cleirigh C, Olivier S, et al
    HIV, multimorbidity, and health-related quality of life in rural KwaZulu-Natal, South Africa: A population-based study.
    PLoS One. 2024;19:e0293963.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016